USE OF STIMULATED PERIPHERAL BLOOD MONONUCLEAR CELLS FOR TREATING CANCEROUS DISEASES

Title:

USE OF STIMULATED PERIPHERAL BLOOD MONONUCLEAR CELLS FOR TREATING CANCEROUS DISEASES

Document Type and Number:

WIPO Patent Application WO2002087612

Kind Code:

A3

Abstract:

The invention relates to the use of peripheral blood mononuclear cells that have been stimulated by means of cascade memory imprinting (cascade primed (CAPRI) cells) for providing an agent for treating cancerous diseases. The CAPRI cells can also be administered in combination with CD3-activated cells.

Inventors:

WANK RUDOLF (DE)

Application Number:

PCT/EP2002/004524

Publication Date:

January 09, 2003

Filing Date:

April 24, 2002

Export Citation:

Click for automatic bibliography generation Help

Assignee:

WANK RUDOLF (DE)

International Classes:

A61K35/15; A61K35/17; A61K39/00; A61P35/00; A61P43/00; C12N5/08; (IPC1-7): A61K39/00; A61K35/14; A61P35/00

Domestic Patent References:

WO1999050393A2	1999-10-07
WO1996029394A1	1996-09-26
WO1995020349A1	1995-08-03

Other References:

TAKAYAMA TADATOSHI ET AL: "Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: A randomised trial.", LANCET (NORTH AMERICAN EDITION), vol. 356, no. 9232, 2000, pages 802 - 807, XP002215496, ISSN: 0099-5355

Download PDF:

View/Download PDF PDF Help

Previous Patent: AGENT OF HUMAN ORIGIN FOR VACCINATION AGAINST GD2 POSITIVE TUMOURS

Next Patent: MULTIVALENT VACCINE COMPRISING AN HIV ANTIGEN AND AN HSV ANTIGEN AND/OR AN HPV ANTIGEN